{
    "clinical_study": {
        "@rank": "16634", 
        "arm_group": [
            {
                "arm_group_label": "group with a preeclampsia before 34 SA", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "group with a normal pregnancy", 
                "arm_group_type": "Other"
            }
        ], 
        "brief_summary": {
            "textblock": "Preeclampsia is a frequent pathology. His etiology is doubtful.\n\n      Targets :\n\n      The study target is to identify a risk of preeclampsia group obtained with transcriptom\n      analysis from circulating peripheric cells.\n\n      Design:\n\n      Multidisciplinary study  (Gynaecology-Obstetric, Immunology, North CIC).\n\n      The study of the transcriptional history of peripheral blood cells of 2patients groups:\n\n        -  A patient group with a preeclampsia before 34 SA\n\n        -  A patient group with a normal pregnancy paired on main confusion factors. Blood\n           sampling will be collected at the diagnosis and 8 weeks after delivery.\n\n      Results and perspectives\n\n        -  Obtain a transcriptionnal signature of preeclampsia\n\n        -  To identify new mechanism of the disease\n\n        -  Identification of a specific  transcriptom analysis with the comparison after delivery\n           For long-term, the target is to identify risk patient in order to conduct easily\n           preventive clinical trials in preeclamsia (primary prevention) and to consider a\n           specific follow-up for risk patients."
        }, 
        "brief_title": "Micro Array Analysis in Preeclampsia", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Preeclampsia", 
        "condition_browse": {
            "mesh_term": "Pre-Eclampsia"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  A pr\u00e9\u00e9clampsie (blood pressure superior to 140 mmHg and to 90 mmHg) and at least a\n             cross of protein in the strip and/or more of 300mg / 24h after 20 LIMITED COMPANIES\n             and before 34 limited companies.\n\n          -  An informed consent signed by the patient will necessarily have to be obtained.\n\n          -  Woman having been taken care during the pregnancy or at the time of the\n             childbirth(delivery) by one of the participating teams to the current project.\n\n          -  Caucasian Patient\n\n          -  Wait primigeste and nullipare\n\n        Exclusion Criteria:\n\n          -  Major Patient protected by the law.\n\n          -  Patient deprived of freedom for administrative or judicial reasons.\n\n          -  Patient not benefiting from a national insurance scheme.\n\n          -  Refusal of the patient to participate in the study.\n\n          -  Not Caucasian Patient\n\n          -  Multipare Wait\n\n          -  Multiple Pregnancy\n\n          -  Existence of foetal deformation explaining a delay of growth or a foetal death in\n             utero.\n\n          -  Age 18 years and > 40 years.\n\n          -  Absence of written consent or impossibility to receive the written consent (language\n             or understanding)."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "40 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 11, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01914809", 
            "org_study_id": "2010-A00633-36", 
            "secondary_id": "2010-04"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "group with a preeclampsia before 34 SA", 
                    "group with a normal pregnancy"
                ], 
                "intervention_name": "samples blood", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": [
                    "group with a preeclampsia before 34 SA", 
                    "group with a normal pregnancy"
                ], 
                "intervention_name": "biopsy placentaire", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "July 31, 2013", 
        "location": {
            "contact": {
                "email": "florence.bretelle@ap-hm.fr", 
                "last_name": "florence bretelle"
            }, 
            "facility": {
                "address": {
                    "city": "Marseille", 
                    "country": "France", 
                    "zip": "13354"
                }, 
                "name": "Assistance Publique Hopitaux de Marseille"
            }, 
            "investigator": {
                "last_name": "florence bretelle", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Micro Array Analysis in Preeclampsia", 
        "overall_contact": {
            "email": "florence.bretelle@ap-hm.fr", 
            "last_name": "florence bretelle"
        }, 
        "overall_official": {
            "affiliation": "Assistance Publique Hopitaux De Marseille", 
            "last_name": "LOIC MONDOLONI", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "blood samples", 
            "measure": "predictive markers of preeclampsia", 
            "safety_issue": "No", 
            "time_frame": "36 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01914809"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "biopsie placentaire", 
            "measure": "analysis of placental transcriptional profile.", 
            "safety_issue": "No", 
            "time_frame": "36 months"
        }, 
        "source": "Assistance Publique Hopitaux De Marseille", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Assistance Publique Hopitaux De Marseille", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2011", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}